0000911916-15-000152.txt : 20150507 0000911916-15-000152.hdr.sgml : 20150507 20150507123313 ACCESSION NUMBER: 0000911916-15-000152 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150505 FILED AS OF DATE: 20150507 DATE AS OF CHANGE: 20150507 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CoLucid Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001348649 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203419541 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-365-2596 MAIL ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 FORMER COMPANY: FORMER CONFORMED NAME: Colucid Pharmaceuticals Inc DATE OF NAME CHANGE: 20060104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dallas Matthew D CENTRAL INDEX KEY: 0001612396 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37358 FILM NUMBER: 15840471 MAIL ADDRESS: STREET 1: AVEO PHARMACEUTICALS, INC. STREET 2: 650 EAST KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-05-05 0001348649 CoLucid Pharmaceuticals, Inc. CLCD 0001612396 Dallas Matthew D 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 0 1 0 0 Chief Financial Officer Employee Stock Option (Right to Buy) 10.00 2015-05-05 4 A 0 180254 0 A 2025-05-05 Common Stock 180254 180254 D Options vest as follows: 25% of the shares vest on May 5, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service. /s/ Miranda S. Hirner, Attorney-in-Fact for Matthew D. Dallas (power of attorney previously filed) 2015-05-07